Consolidated Statement of Stockholders' Equity (Deficit) - USD ($) $ in Thousands |
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member]
Noncontrolling Interest [Member]
|
Cumulative Effect, Period of Adoption, Adjustment [Member] |
The 2023 Series X Private Placement [Member]
Preferred Stock [Member]
The 2022 Private Placement [Member]
|
The 2023 Series X Private Placement [Member]
Preferred Stock [Member]
Multi-Tranche Private Placement 2023 [Member]
|
The 2023 Series X Private Placement [Member]
Preferred Stock [Member]
The 2023 Series X Private Placement Shares [Member]
|
The 2023 Series X Private Placement [Member]
Preferred Stock [Member]
The 2024 Series Y Private Placement [Member]
|
The 2023 Series X Private Placement [Member]
Common Stock [Member]
|
The 2023 Series X Private Placement [Member]
Additional Paid-in Capital [Member]
|
The 2023 Series X Private Placement [Member]
Retained Earnings [Member]
|
The 2023 Series X Private Placement [Member]
Noncontrolling Interest [Member]
|
The 2023 Series X Private Placement [Member] |
Private Placement [Member]
Preferred Stock [Member]
The 2022 Private Placement [Member]
|
Private Placement [Member]
Preferred Stock [Member]
Multi-Tranche Private Placement 2023 [Member]
|
Private Placement [Member]
Preferred Stock [Member]
The 2023 Series X Private Placement Shares [Member]
|
Private Placement [Member]
Preferred Stock [Member]
The 2024 Series Y Private Placement [Member]
|
Private Placement [Member]
Common Stock [Member]
|
Private Placement [Member]
Additional Paid-in Capital [Member]
|
Private Placement [Member]
Retained Earnings [Member]
|
Private Placement [Member]
Noncontrolling Interest [Member]
|
Private Placement [Member] |
Preferred Stock [Member]
The 2022 Private Placement [Member]
|
Preferred Stock [Member]
Multi-Tranche Private Placement 2023 [Member]
|
Preferred Stock [Member]
The 2023 Series X Private Placement Shares [Member]
|
Preferred Stock [Member]
The 2024 Series Y Private Placement [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance (in shares) at Dec. 31, 2022 | 3,185,000 | 0 | 0 | 0 | 518,745 | |||||||||||||||||||||||||||
| Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 | $ 0 | $ (548) | $ (548) | |||||||||||||||||||||||||||||
| Balance at Dec. 31, 2022 | $ 29 | $ 232,169 | $ (224,105) | $ 645 | $ 8,738 | |||||||||||||||||||||||||||
| Net loss — the Company | 0 | 0 | (37,250) | 0 | (37,250) | |||||||||||||||||||||||||||
| Net income attributable to non-controlling interest | 0 | 0 | 0 | 200 | 200 | |||||||||||||||||||||||||||
| Dividends from subsidiaries | $ 0 | (275) | (275) | |||||||||||||||||||||||||||||
| Restricted share units vested (in shares) | 0 | 0 | 0 | 0 | 2,250 | |||||||||||||||||||||||||||
| Restricted share units vested | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
| Issuance of stock (in shares) | 0 | 0 | 256,356 | 0 | 0 | 0 | 1,575,810 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31,210 | |||||||||||||||||
| Issuance of stock | $ 0 | $ 7,040 | $ 0 | $ 0 | $ 7,040 | $ 0 | $ 3,694 | $ 0 | $ 0 | $ 3,694 | $ 1 | 815 | 0 | 0 | 816 | |||||||||||||||||
| Beneficial conversion feature | 0 | 2,567 | 0 | 0 | 2,567 | |||||||||||||||||||||||||||
| Stock-based compensation | $ 0 | 1,569 | 0 | 0 | 1,569 | |||||||||||||||||||||||||||
| Balance (in shares) at Dec. 31, 2023 | 3,185,000 | 1,575,810 | 256,356 | 0 | 552,205 | |||||||||||||||||||||||||||
| Balance at Dec. 31, 2023 | $ 30 | 247,854 | (261,903) | 570 | (13,449) | |||||||||||||||||||||||||||
| Net loss — the Company | 0 | 0 | (46,996) | 0 | (46,996) | |||||||||||||||||||||||||||
| Net income attributable to non-controlling interest | 0 | 0 | 0 | 25 | 25 | |||||||||||||||||||||||||||
| Dividends from subsidiaries | $ 0 | 0 | 0 | (126) | (126) | |||||||||||||||||||||||||||
| Issuance of stock (in shares) | 0 | 0 | 0 | 0 | 758 | |||||||||||||||||||||||||||
| Issuance of stock | 10 | 0 | 0 | 10 | ||||||||||||||||||||||||||||
| Stock-based compensation | $ 0 | 1,043 | 0 | 0 | 1,043 | |||||||||||||||||||||||||||
| 2024 Registered Direct Offering shares and warrants, net of costs (in shares) | 0 | 0 | 0 | 0 | 74,342 | |||||||||||||||||||||||||||
| 2024 Registered Direct Offering shares and warrants, net of costs | 977 | 0 | 0 | 977 | ||||||||||||||||||||||||||||
| 2023 Series X Private Placement shares dividends (in shares) | 0 | 0 | 33,580 | 0 | 0 | |||||||||||||||||||||||||||
| 2023 Series X Private Placement shares dividends | $ 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
| Conversion of 2022 Private Placement shares (in shares) | (1,350,000) | |||||||||||||||||||||||||||||||
| Conversion of 2022 Private Placement shares (in shares) | 0 | 0 | 0 | 81,825 | ||||||||||||||||||||||||||||
| Conversion of 2022 Private Placement shares | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||
| Exchange of MSLP Loan for Series Y Private Placement shares (in shares) | 0 | 0 | 0 | 780,569 | 0 | |||||||||||||||||||||||||||
| Exchange of MSLP Loan for Series Y Private Placement shares | $ 0 | 61,354 | 0 | 0 | 61,354 | |||||||||||||||||||||||||||
| Balance (in shares) at Dec. 31, 2024 | 1,835,000 | 1,575,810 | 289,936 | 780,569 | 709,130 | |||||||||||||||||||||||||||
| Balance at Dec. 31, 2024 | $ 30 | $ 311,238 | $ (308,899) | $ 469 | $ 2,838 |
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued to shareholders as a dividend during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A convertible instrument contains a BCF when the conversion price is less than the fair value of the shares into which the instrument is convertible at the commitment date. The conversion option related to the Series A convertible preferred shares has intrinsic value at the issuance date and will therefore be recorded as a beneficial conversion feature. A BCF would be separated from a convertible instrument and recorded in additional paid-in capital. No definition available.
|
| X | ||||||||||
- Definition Number of new stocks issued during the period, net of cost. No definition available.
|
| X | ||||||||||
- Definition Net equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. No definition available.
|
| X | ||||||||||
- Details
|